SAN-2219

N/A

Report date: 2024/12/16 10:11:56

NME

Base Information

Drug NameSAN-2219

Drug Alias NameSAN-2219

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-3 modulatorsGamma-aminobutyric acid A receptor alpha-2 modulatorsGamma-aminobutyric acid A receptor alpha-5 modulators

TargetsGamma-aminobutyric acid A receptor alpha-3Gamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-5

Therapy Area/IndicationsEpilepsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSaniona A/S

China Registration ClassN/A

Develop Information

Active CompaniesSaniona A/S

Inactive CompaniesN/A

Active IndicationsEpilepsy

Inactive IndicationsN/A

Other Information

ATC CodeN/A